Baxion
Screening
Tags
Alerts
Theme
Tiziana Life Sciences Ltd.
TLSA
·
NASDAQ
·
$1.51
Share Price as of 11/2
·
$90M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
20-F
Annual report (foreign)
05/01/26
20-F/A
Annual report (foreign, amended)
05/08/25
20-F
Annual report (foreign)
05/06/25
20-F
Annual report (foreign)
05/10/24
20-F/A
Annual report (foreign, amended)
06/13/23
Disclosures
Filter
6-K
Foreign issuer report
10/21/26
6-K
Foreign issuer report
10/16/26
6-K
Foreign issuer report
10/16/26
6-K
Foreign issuer report
09/30/26
6-K
Foreign issuer report
09/28/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
02/20/26
424B5
Prospectus supplement
01/22/26
POS AM
Post-effective amendment
01/21/26
424B5
Prospectus supplement
01/16/26
424B5
Prospectus supplement
12/12/25
Proxies
Filter
No matching filings.
Ownership
Filter
Form 4
Insider transaction
09/29/26
4/A
Insider transaction (amended)
08/07/26
4/A
Insider transaction (amended)
08/07/26
Form 4
Insider transaction
08/06/26
Form 4
Insider transaction
08/05/26
Other
Filter
NT 20-F
Late filing notification (20-F)
04/30/26
AW
Withdrawal request
01/22/26
NT 20-F
Late filing notification (20-F)
04/30/25
CORRESP
Correspondence with the SEC
03/27/25
EFFECT
Request for effectiveness
03/27/25
Latest Filings
Filter
6-K
Foreign issuer report
10/21/26
6-K
Foreign issuer report
10/16/26
6-K
Foreign issuer report
10/16/26
6-K
Foreign issuer report
09/30/26
6-K
Foreign issuer report
09/28/26
Ownership
Filter
Form 4
Insider transaction
09/29/26
4/A
Insider transaction (amended)
08/07/26
4/A
Insider transaction (amended)
08/07/26
Form 4
Insider transaction
08/06/26
Form 4
Insider transaction
08/05/26